Skip to main content
Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
4.320
+0.140 (3.35%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Evaxion Revenue

In the year 2025, Evaxion had annual revenue of $7.53M with 125.12% growth.

Revenue (ttm)
$7.53M
Revenue Growth
+125.12%
P/S Ratio
4.79
Revenue / Employee
$163,652
Employees
46
Market Cap
36.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.53M4.18M125.12%
Dec 31, 20243.34M3.27M4,480.82%
Dec 31, 202373.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Celularity 40.58M
Palatin Technologies 8.96M
CervoMed 4.01M
Dyadic International 3.09M
Pluri 1.34M
IGC Pharma 1.11M
Outlook Therapeutics 205.70K
Senti Biosciences 22.00K
Revenue Rankings

EVAX News

More News